Evaluation of Faisability, Safety and Effectiveness and of Discogel in Patients With Aneurysmal and Simple Bone Cysts
Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE SAINT ETIENNE · May 26, 2023
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a treatment called Discogel for patients with aneurysmal and simple bone cysts. Bone cysts are fluid-filled sacs that can form in the bones, and while there are various treatments, there isn't a clear agreement on the best approach to take. The aim of this trial is to see if Discogel is a safe and effective option for treating these cysts.
To participate in this study, you need to have either an aneurysmal or simple bone cyst that could benefit from treatment with Discogel. The trial is open to people of all ages and genders. If you choose to join, you’ll receive treatment with Discogel, and the researchers will monitor your health and progress. It's important to note that if you don’t want to participate, that’s perfectly fine, and you won't be included in the trial.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient with aneurysmal or simple bone cyst who benefit a sclerotherapy by Discogel
- Exclusion Criteria:
- • Refusal
About Centre Hospitalier Universitaire De Saint Etienne
The Centre Hospitalier Universitaire (CHU) de Saint-Étienne is a leading academic medical center in France, dedicated to advancing healthcare through innovative clinical research and high-quality patient care. With a robust infrastructure that supports a wide range of medical specialties, CHU de Saint-Étienne fosters collaboration between healthcare professionals, researchers, and academic institutions. The center is committed to conducting rigorous clinical trials that adhere to ethical standards and regulatory requirements, aiming to improve treatment outcomes and enhance the overall health of the community. Through its dedication to scientific excellence and patient-centered care, CHU de Saint-Étienne plays a pivotal role in the advancement of medical knowledge and the development of new therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Saint étienne, , France
Patients applied
Trial Officials
Sylvain Grange, MD
Principal Investigator
CHU SAINT-ETIENNE
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported